Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lotersztajn

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Pathologie-Biologie|February 1, 1993
[Endothelins and their non-vascular effects]S Lotersztajn
Journal of Endocrinological Investigation|June 6, 2006
Endocannabinoids as novel mediators of liver diseasesA Mallat, S Lotersztajn
Journal of Hepatology|September 1, 1996
Multiple hepatic functions of endothelin-1: physiopathological relevanceA Mallat, S Lotersztajn
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Endocannabinoids and their role in fatty liver diseaseA Mallat, S Lotersztajn
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 3, 2007
Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liverA Mallat, S Lotersztajn
The Journal of Biological Chemistry|January 25, 1985
Fe2+ and other divalent metal ions uncouple Ca2+ transport from (Ca2+-Mg2+)-ATPase in rat liver plasma membranesF Pecker, S Lotersztajn
Annals of the New York Academy of Sciences|January 1, 1982
The liver plasma membrane Ca-ATPaseF Pecker, S Lotersztajn
Gastroenterologie Clinique Et Biologique|June 30, 2009
[Liver fibrosis: from pathophysiology to therapeutic openings]A Mallat, S Lotersztajn
Diabetes & Metabolism|February 7, 2009
Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitisA Mallat, S Lotersztajn
The Journal of Biological Chemistry|June 25, 1982
A membrane-bound protein inhibitor of the high affinity Ca ATPase in rat liver plasma membranesS Lotersztajn, F Pecker
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Pathologie-Biologie|February 1, 1993
[Endothelins and their non-vascular effects]S Lotersztajn
Journal of Endocrinological Investigation|June 6, 2006
Endocannabinoids as novel mediators of liver diseasesA Mallat, S Lotersztajn
Journal of Hepatology|September 1, 1996
Multiple hepatic functions of endothelin-1: physiopathological relevanceA Mallat, S Lotersztajn
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Endocannabinoids and their role in fatty liver diseaseA Mallat, S Lotersztajn
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 3, 2007
Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liverA Mallat, S Lotersztajn
The Journal of Biological Chemistry|January 25, 1985
Fe2+ and other divalent metal ions uncouple Ca2+ transport from (Ca2+-Mg2+)-ATPase in rat liver plasma membranesF Pecker, S Lotersztajn
Annals of the New York Academy of Sciences|January 1, 1982
The liver plasma membrane Ca-ATPaseF Pecker, S Lotersztajn
Gastroenterologie Clinique Et Biologique|June 30, 2009
[Liver fibrosis: from pathophysiology to therapeutic openings]A Mallat, S Lotersztajn
Diabetes & Metabolism|February 7, 2009
Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitisA Mallat, S Lotersztajn
The Journal of Biological Chemistry|June 25, 1982
A membrane-bound protein inhibitor of the high affinity Ca ATPase in rat liver plasma membranesS Lotersztajn, F Pecker
Pageof 5